Paris, France

Elodie Lewkowicz

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 11.9

ph-index = 1


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Elodie Lewkowicz: Pioneer in Medicinal Chemistry

Introduction

Elodie Lewkowicz, based in Paris, France, is an innovative inventor renowned for her contributions to the field of medicinal chemistry. With a total of three patents to her name, she has made significant strides in developing compounds that hold promise for treating serious medical conditions.

Latest Patents

Elodie’s latest patents include two notable inventions. The first is focused on "Substituted piperidines as inhibitors of ubiquitin-specific protease 7." This comprises compounds of formula (I), wherein R, R, R, B, W, Z, m, and n are specifically defined in the accompanying description. The second patent addresses "Substituted piperidines for the treatment of cancer," along with medicinal products containing these compounds that are useful in treating conditions that require pro-apoptotic and/or anti-proliferative agents.

Career Highlights

Elodie has had a remarkable career, with significant roles at reputable organizations such as Les Laboratoires Servier and Vernalis Limited (R&D). Her work has focused on advancing therapeutic options and enhancing our understanding of drug mechanisms.

Collaborations

Throughout her career, Elodie has collaborated with esteemed colleagues, including András Kotschy and Csaba Wéber. These collaborations have likely enriched her research and led to innovative outcomes in the domain of medicinal chemistry.

Conclusion

Elodie Lewkowicz stands out as an influential inventor whose work and patents are paving the way for advancements in the treatment of cancer and other medical conditions. Her dedication to innovation and collaboration marks her as a key figure in the medicinal chemistry landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…